XYL

SEC source: 0001209191-22-007423 · doc5.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Steven R Loranger Revocable Trust

Disclosed balance after: 46,407

F1 · shares: On December 14, 2021, 12,491 shares of Xylem Inc. common stock were transferred from the Steven R Loranger Revocable Trust to the Steve and Betsy Loranger Foundation.

SEC source: 0001209191-21-067548 · doc4.xml · derivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,423

Underlying: Common · 2,000 shares

Expires 2030-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023.

SEC source: 0001209191-21-067548 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,217

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 441 Shares were sold at a range of prices from $118.56 to $119.23. 200 Shares were sold at a range of prices from $119.66 to $120.37. 400 Shares were sold at a range of prices from $120.94 to $121.61. 601 Shares were sold at a range of prices from $121.94 to $122.79. 358 Shares were sold at a range of prices from $122.97 to $123.27. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-067548 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,217

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-063864 · doc4.xml · derivative · entry 3

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,298

Underlying: Common · 54,643 shares

Expires 2024-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-063864 · doc4.xml · nonDerivative · entry 2

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,889

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 26,858 Shares were executed at a range of prices from $131.93 to $132.92. 27,785 Shares were executed at a range of prices from 132.93 to $133.75. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-063864 · doc4.xml · nonDerivative · entry 1

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-063232 · doc4.xml · derivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,423

Underlying: Common · 2,000 shares

Expires 2030-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023.

SEC source: 0001209191-21-063232 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,217

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-063232 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,217

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-063127 · doc4.xml · nonDerivative · entry 1

Flinton David · CIK 0001654800 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,960

F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on November 4, 2019 under the Xylem 2011 Omnibus Incentive Plan

SEC source: 0001209191-21-061248 · doc4.xml · derivative · entry 7

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,606

Underlying: Common · 1,900 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-061248 · doc4.xml · derivative · entry 6

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,506

Underlying: Common · 1,900 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-061248 · doc4.xml · nonDerivative · entry 5

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,485

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,595 Shares were executed at a range of prices from $125.33 to $126.23. 200 Shares were executed at a range of prices from $126.36 to $126.42. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-061248 · doc4.xml · nonDerivative · entry 4

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,280

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,808 Shares were executed at a range of prices from $125.31 to $126.26. 92 Shares were executed at a price of $126.56. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-061248 · doc4.xml · nonDerivative · entry 3

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-061248 · doc4.xml · nonDerivative · entry 2

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,280

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,756 Shares were executed at a range of prices from $125.32 to $126.26. 144 Shares were executed at a range of prices from $126.38 to $126.57. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-061248 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-059133 · doc4.xml · derivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,423

Underlying: Common · 2,000 shares

Expires 2030-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023.

SEC source: 0001209191-21-059133 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,217

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 472 Shares were executed at a range of prices from $119.96 to $120.92. 1,128 Shares were executed at a range of prices from $121.11 to $122.02. 400 Shares were executed at a range of prices from $122.38 to $122.72. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-059133 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,217

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-056152 · doc4.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Tambakeras Family Trust

Disclosed balance after: 25,062

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $131.94 to $132.01. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-054451 · doc4.xml · derivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,423

Underlying: Common · 2,000 shares

Expires 2030-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023.

SEC source: 0001209191-21-054451 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,217

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 794 Shares were executed at a range of prices from $135.44 to $136.43. 1,204 Shares were executed at a range of prices from $136.44 to $136.84. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-054451 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,217

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-050656 · doc4.xml · derivative · entry 4

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,941

Underlying: Common · 54,643 shares

Expires 2024-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-050656 · doc4.xml · nonDerivative · entry 3

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,889

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 6,068 Shares were executed at a range of prices from $128.29 to $129.26. 48,133 Shares were executed at a range of prices from 129.29 to $130.27. 442 Shares were executed at a range of prices from $130.32 to $130.42. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-050656 · doc4.xml · nonDerivative · entry 2

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021.

SEC source: 0001209191-21-050587 · doc4.xml · derivative · entry 4

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,423

Underlying: Common · 2,000 shares

Expires 2030-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023.

SEC source: 0001209191-21-050587 · doc4.xml · nonDerivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,217

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a prices ranging from $128.04 to $128.79. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-050587 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,021

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $128.06 to $128.77. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-050587 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,021

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-050656 · doc4.xml · nonDerivative · entry 1

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,889

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $127.92 to $128.66. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-047358 · doc4.xml · derivative · entry 8

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,406

Underlying: Common · 1,900 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-047358 · doc4.xml · derivative · entry 7

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,306

Underlying: Common · 1,900 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-047358 · doc4.xml · nonDerivative · entry 6

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,280

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-047358 · doc4.xml · nonDerivative · entry 5

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,485

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,390 Shares were executed at a range of prices from $116.28 to $117.25. 200 Shares were executed at a range of prices from $117.34 to $117.79. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-047358 · doc4.xml · nonDerivative · entry 4

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,075

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-047358 · doc4.xml · nonDerivative · entry 3

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,975

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-047358 · doc4.xml · nonDerivative · entry 2

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,075

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,600 Shares were executed at a range of prices from $116.31 to $117.27. 300 Shares were executed at a range of prices from $117.33 to $117.79. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-047358 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,975

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-046897 · doc4.xml · derivative · entry 3

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common · 5,956 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-046897 · doc4.xml · nonDerivative · entry 2

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,109

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,407 Shares were executed at a range of prices from $118.92 to $119.91. 2,849 Shares were executed at a range of prices from $119.94 to $120.93. 700 Shares were executed at a range of prices from $120.94 to $121.25. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F3 · balance_after: Includes 48,065 shares held by the Claudia S. Toussaint Revocable Trust.

SEC source: 0001209191-21-046897 · doc4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-046482 · doc4.xml · nonDerivative · entry 1

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 256,199

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 9,154 Shares were executed at a range of prices from $120.26 to $121.23. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-047725 · doc4.xml · nonDerivative · entry 1

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,995

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 9,204 Shares were executed at a range of prices from $122.50 to $122.75. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-044833 · doc4.xml · derivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,423

Underlying: Common · 2,000 shares

Expires 2030-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023.

SEC source: 0001209191-21-044833 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,021

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,900 Shares were executed at a range of prices from $119.93 to $120.41. 100 Shares were executed at a price of $121.11. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-044833 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,021

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-041394 · doc4.xml · derivative · entry 6

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,956

Underlying: Common · 5,781 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested and exercisable.